#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hodgkin's disease recurrent Ductal adenocarcinoma of pancreas Cortical dysplasia Malformation venous Richter's syndrome Dementia Porphyria non-acute Diabetes insipidus Cutaneous lupus erythematosus Hyperinsulinism Mantle cell lymphoma recurrent Retinitis pigmentosa White matter lesion Cutaneous T-cell lymphoma Netherton's syndrome More trials…

    Learn about Rare Diseases

    Bronchiolitis obliterans syndrome – Diagnostics Aicardi-Goutieres syndrome Osteosarcoma recurrent – Diagnostics Immunodeficiency congenital Rhabdoid tumour – Basic Information Alport’s syndrome – Diagnostics Immunodeficiency congenital – Basic Information Primary mediastinal large B-cell lymphoma – Treatment Wiskott-Aldrich syndrome – Basic Information Leiomyosarcoma recurrent – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Risankizumab Sulfamethoxazole Gns561 Alkaline Phosphatase, Bovine Inupadenant Maralixibat Chloride Sasanlimab Ublituximab Triamcinolone Taplucainium Chloride Cobolimab Ecoo75 Lenacapavir Sodium ALXN2420 Nofazinlimab Tasimelteon Stro-002 Benztropine Mesylate Mometasone Furoate Ph. Eur. Fludarabine Phosphate Ph. Eur. More therapies…

    Learn about Your Condition

    Papillary thyroid cancer Large cell lung cancer stage 0 Caesarean section Cluster headache Alveolar rhabdomyosarcoma Renal cell carcinoma Infant sedation Breast cancer stage III Haemorrhagic stroke Diabetic foot Injury Phenylketonuria Hypertonic bladder Tuberous sclerosis complex Behavioural addiction More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Physiological processes

  • Study on Zolpidem’s Effects in Patients with Vision Impairments, Disorders of Consciousness, and Neurotypical Volunteers

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • ZOLPIDEM TARTRATE
    • Mannitol
    Belgium

  • Study Comparing Intramuscular and Intranasal Naloxone for Reversing Opioid Overdose in Healthy Volunteers

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Naloxone Hydrochloride
    • Fentanyl Citrate
    The Netherlands

  • Study on Reducing Body Temperature in Healthy Volunteers Using Pethidine and Buspirone to Prevent Shivering

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Buspirone Hydrochloride
    • Epinephrine Bitartrate
    • PETHIDINE HYDROCHLORIDE
    Norway

  • Study on the Effects of Esketamine and Remifentanil on Breathing in Healthy Volunteers

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Naloxone Hydrochloride
    • Remifentanil
    • Esketamine
    The Netherlands

  • Study on Reversing Opioid-Induced Breathing Problems Using Naloxone and Nalmefene in Healthy Volunteers and Opioid Users

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Drug use disorder
    Investigated Drugs:
    • NALMEFENE HYDROCHLORIDE
    • Naloxone Hydrochloride
    • Ondansetron Hydrochloride Dihydrate
    The Netherlands

  • Study on the Use of Indocyanine Green to Assess Lymphatic Vessel Porosity in Women with Lipedema

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Indocyanine Green
    Belgium
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!